FDA Inspection
CSL Behring GmbHCSL Behring GmbH – FDA Inspection, Apr 30, 2024
Record Details
This FDA Inspection record concerns CSL Behring GmbH, with an inspection on April 30, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 000b7826-6f26-4e9b-a0d2-c32326a18a4b
Inspection Facts
- Inspection number
- 1242677
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of CSL Behring GmbH
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 18, 2026 | Not classified | Office of Inspections and Investigations | Blood and Blood Products |
| April 18, 2024 | Not classified | Office of Inspections and Investigations | Compliance: Devices |
| March 4, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 17, 2018 | Not classified | Office of Inspections and Investigations | |
| May 17, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Behring GmbH
- FDA Inspection 1298394 - 2026-02-18
- FDA Inspection 1231683 - 2024-04-18
- FDA Inspection 1166653 - 2022-03-04
- FDA Inspection 1052244 - 2018-05-17
- FDA Inspection 1007037 - 2016-05-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.